Webinar

From candidate selection through to proof-of-concept

12th International ISSX Meeting

Headed to the 12th International ISSX Meeting?

Come by Quotient Sciences' booth #210 to meet with our Director 14C Drug Development, Client Services, Iain Shaw and Sr. Director of Business Development, Katie Stuart.  Both will be hand to share Quotient's integrated solutions for first-in-human and clinical pharmacology programs.

We will also be presenting two posters at the event:

Poster 46: “UNDERSTANDING THE EXCRETION PROFILE AND THE METABOLISM OF PITOLISANT IN CYP450 2D6 POOR AND EXTENSIVE METABOLISERS AT STEADY STATE” to be presented in Poster Session 1 which will be held on Monday, 29 July from 12:00-13:00
 

Poster 47: “AN INTEGRATED RADIOLABELLED STUDY TO DETERMINE THE ABSORPTION, METABOLISM, EXCRETION AND ABSOLUTE BIOAVAILABILITY OF PEMAFIBRATE IN HEALTHY MALE SUBJECTS” to be presented in Poster Session 1, Monday, 29 July from 11:00-12:00

To schedule a meeting with Iain and Katie at the event click here.

Event: 12th International ISSX Meeting
When: July 28 - 31
Where: Oregon Convention Center in Portland, OR
Event Website: https://www.issx2019.org/

Drug product development

Take a look at our expert resources

Ask us a question